A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors
Clinical trial NCT05502393 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05502393
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-26
- Primary completion
- 2027-12-31
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.